1. Suzuki, Chie, Fujiwara, Tohru, Shima, Hiroki, Igarashi, Kazuhiko, Harigae, Hideo. 2022. Elucidation of the Role of FAM210B in Mitochondrial Metabolism and Erythropoiesis. In Molecular and cellular biology, 42, e0014322. doi:10.1128/mcb.00143-22. https://pubmed.ncbi.nlm.nih.gov/36374104/
2. Perfetto, Mark, Rondelli, Catherine M, Gillis, Samantha, Stratman, Amber N, Yien, Yvette Y. 2023. FAM210B is dispensable for erythroid differentiation in adult mice. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.09.26.559581. https://pubmed.ncbi.nlm.nih.gov/37823037/
3. Zhou, Yuanqin, Pan, Xianzhu, Liu, Yakun, Kan, Chen, Zheng, Hong. 2023. Loss of the Novel Mitochondrial Membrane Protein FAM210B Is Associated with Hepatocellular Carcinoma. In Biomedicines, 11, . doi:10.3390/biomedicines11041232. https://pubmed.ncbi.nlm.nih.gov/37189851/
4. Sun, Shujuan, Liu, Jia, Zhao, Meisong, Gao, Qinglei, Wu, Peng. 2017. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming. In Cell death & disease, 8, e2870. doi:10.1038/cddis.2017.273. https://pubmed.ncbi.nlm.nih.gov/28594398/
5. Yien, Yvette Y, Shi, Jiahai, Chen, Caiyong, Lodish, Harvey F, Paw, Barry H. 2018. FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. In The Journal of biological chemistry, 293, 19797-19811. doi:10.1074/jbc.RA118.002742. https://pubmed.ncbi.nlm.nih.gov/30366982/
6. Friedlander, Philip, Wood, Kevin, Wassmann, Karl, Bhardwaj, Nina, Oh, William K. 2018. A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. In Journal for immunotherapy of cancer, 6, 90. doi:10.1186/s40425-018-0408-9. https://pubmed.ncbi.nlm.nih.gov/30227886/
7. Li, Haoguang, Zhou, Lu, Zhou, Wei, Zhang, Rongwei, Duan, Xinwang. 2023. Decoding the mitochondrial connection: development and validation of biomarkers for classifying and treating systemic lupus erythematosus through bioinformatics and machine learning. In BMC rheumatology, 7, 44. doi:10.1186/s41927-023-00369-0. https://pubmed.ncbi.nlm.nih.gov/38044432/
智鼠故事 
